Download 2025 Global and China biotech sector survey reports
Two new reports of surveys of 260+ Global and China biotech leaders have just been released
What are the 2025 reports about?
In 2025 ICON Biotech surveyed over 260 biotech leaders, in China and worldwide. The global survey report tracks the changes since our 2023 survey. The supplemental China report focuses on the experiences of 100 biotech leaders, within this significant biotech region.
Download both reports for insights into what biotech expects in 2026
2025
Global biotech sector survey
Our latest survey of 163 biotech leaders explores the trends shaping innovation worldwide. With added insights from venture capital firms, this survey report reveals how priorities and opportunities are evolving across the biotech ecosystem.
2025
China biotech sector survey
China’s biotech sector has grown rapidly, powered by decades of centralised planning and strong partnerships. As part of ICON’s latest research, we surveyed 100 biotech leaders based in China, to understand the major priorities and challenges facing them.
Insider perspectives from biotech leaders and venture capital experts
Commentary from venture capital (VC) firms adds context and regional perspectives to the survey responses of 163 global and 100 China-based biotech leaders. The global report explores China’s position as a biotech powerhouse and how the rest of the world plans to respond to these threats and opportunities. The China report assesses the biotech sector from within the country which has overtaken the US for new drug development.
Watch to discover key insights from the reports
2025 Global biotech sector survey
Еxplore insights from 163 biotech leaders and venture capital experts. See how funding pressures, therapeutic priorities, and innovation trends have shifted since 2023.
2025 China biotech sector survey
Gain a regional perspective from 100 executives in a market driving 23% of the global innovative drug pipeline.
What has changed in the biotech sector?
Discover what’s changed globally in 2025, which therapeutic areas have waned and which modalities are on the rise. Learn how geopolitical uncertainty and competition from China are reshaping the sector. Get data-driven insights and anticipate what’s next for biotech including:
- Funding trends
- Therapeutic area activities
- Trends in modalities
- VC commentary
- EU & US responses to China’s biotech growth
- Geopolitical challenges
- The patent cliff and biosimilars
- Biotech sentiment
- Potential opportunities
- Securing the talent pipeline in China